Abstract
Autoimmune hemolytic anemia is rare in children and infants and steroids are the corner stone of therapy. Management of the patients with steroid refractory/dependent disease is difficult .Rituximab is being used in the treatment of a variety of autoimmune diseases including Autoimmune hemolytic anemia (AIHA),especially in adults but there is scarce data regarding the use of this agent in pediatric AIHA patients.The authors report two cases of steroid refractory AIHA, who responded to rituximab with review the literature of its use in pediatrics.
This is a preview of subscription content, log in via an institution to check access.
References
Ware RE, Rose WF. Autoimmune hemolytic anemia. In: Nathan DG, Orkin SH, editors. Nathan and Oski’s hematology of infancy and childhood. Philadelphia: Saunders; 1998. p. 499–522.
Gupta V, Shukla J, Bhatia BD. Autoimmune hemolytic anemia. Indian J Pediatr. 2008;75:451–4.
Agarwal B. Autoimmune hemolytic anemia. Indian J Pediatr. 1998;65:663–8.
Reff ME, Carner K, Chambers S, et al. Depletion of B-cells in vivo by a chimeric mouse monoclonal antibody to CD20. Blood. 1994;83:435–45.
Quartier P, Brethon B, Philippet P, et al. Treatment of childhood autoimmune haemolytic anemia with rituximab. Lancet. 2001;358:1511–3.
Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood. 2003;101:3857–61.
Svahn J, Fioredda F, Calvillo M, et al. Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants. Br J Haematol. 2009;145:96–100.
Rao A, Kelly M, Musselman M, et al. Safety, efficacy and immune reconstitution after Rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias. Pediatr Blood Cancer. 2008;50:822–5.
Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Hematol Oncol Clin North Am. 2010;24:249–73.
Giulino LB, Bussel JB, Neufeld EJ. Treatment with rituximab in benign and malignant hematologic disorders in children. J Pediatr. 2007;150:338–344.e1. doi:10.1016/j.jpeds.2006.12.038.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, N., Sharma, S., Seth, T. et al. Rituximab in Steroid Refractory Autoimmune Hemolytic Anemia. Indian J Pediatr 79, 803–805 (2012). https://doi.org/10.1007/s12098-011-0544-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-011-0544-4